Protocol Ledger

NCT05979961 · Phase III · ACTIVE NOT RECRUITING

Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma

Interventional Phase III clinical trial protocol NCT05979961 sponsored by Sun Yat-sen University in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-09-07 Enrollment: 464 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05979961
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)464 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05979961
Protocol FieldVerified Registry Value
NCT IdentifierNCT05979961
Consolidated Lead SponsorSun Yat-sen University
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment464 participants (ACTUAL)
Registered Start Date2023-09-07
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI